Determination of the Immunoreactivity of Radiolabeled Monoclonal Antibodies: A Theoretical Analysis
Authors:
- 1 February 2006
- journal article
- research article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 21 (1) , 15-21
Abstract
Conjugates of monoclonal antibodies with radioactive nuclides are frequently used in radioimmunotherapy. Because the conjugation procedure may adversely alter the antibody, the immunoreactivity of the antibody must be determined. In this study, we expand the mathematical description of cell-binding assays for the determination of immunoreactivity to include the amount of unlabeled antibody. We describe the relevant equations and constraints and develop a mathematical description of the underlying measurements. The dependence on antibody, on antigen or cell concentration, on the dissociation constant, and on the specific activity is taken into account. The functional dependence of bound labeled antibody on the experimental parameters is given, and the consequences for parameter estimation are discussed. In order to correctly interpret the experimental data for the immunoreactivity, one requires a mathematical model without unnecessary assumptions together with an appropriate nonlinear regression fit.Keywords
This publication has 15 references indexed in Scilit:
- Binding parameters of antibodies: pseudo-affinity and other misconceptionsCancer Immunology, Immunotherapy, 2004
- Determination of Antibody Immunoreactive FractionCancer Biotherapy and Radiopharmaceuticals, 2004
- Determination of Immunoreactive Fraction of Radiolabeled Monoclonal Antibodies: What Is an Appropriate Method?Cancer Biotherapy and Radiopharmaceuticals, 2004
- The Immunoreactivity of Radiolabeled Antibodies—Its Impact on Tumor Targeting and Strategies for PreservationCancer Biotherapy and Radiopharmaceuticals, 2004
- Radioimmunotherapy with 131 I-Rituximab: What We Know and What We Don't KnowCancer Biotherapy and Radiopharmaceuticals, 2003
- Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantationEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Limitations of the Lindmo method in determining antibody immunoreactivityInternational Journal of Cancer, 1995
- Evaluation of labelled monoclonal antibodies by simultaneous estimation of the association constant, the immunoreactive fraction, and the number of effective binding sites on the specific targetJournal of Immunological Methods, 1992
- Determination of immunoreactive fraction and kinetic parameters of a radiolabeled monoclonal antibody in the absence of antigen excessJournal of Immunological Methods, 1991
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984